Pharma Industry News Failed trial dashes Merck’s hopes for Keytruda in first-line bladder cancer 4 years ago
New Drug Applications Almirall Announces FDA Acceptance for Filing of U.S. New Drug Application (NDA) for Tirbanibulin in Actinic Keratosis 4 years ago